Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor and Bortezomib for HLA Desensitization
NCT02522572Phase 2Unknown
- Start
- Aug 2015
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in Human Leukocyte Antigen Sensitization. Status: unknown.
02
Drugs
plerixafor
03
Conditions
Human Leukocyte Antigen Sensitization
Beyond the preview
Go deeper on NCT02522572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02522572.